| List | Section | Observation |
|---|---|---|
| Cuba | 10.2 Modificadores de la coagulación | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation | No observations |
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation | No observations |
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation | No observations |
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation | No observations |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 5.0 Cardiovascular | No observations |
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation |
This medicine requires a children care specialist. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 10.2. Medicines affecting coagulation | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |